A Randomized-Controlled Trial Study of Telecare-Based Interprofessional Collaboration: A New Strategy in Tuberculosis Treatment
Main Article Content
Abstract
To provide optimal treatment for tuberculosis (TB), an interprofessional team is required, but most hospitals cannot provide such standards. A potential alternative method for better medication adherence is telecare. This study aims to develop a telecare service based on interprofessional collaboration to elevate medication adherence and enhance therapy outcomes for individuals with tuberculosis. The research was a single-blind randomized control trial. Data collection was carried out at three points: baseline, one month, and three months post-intervention. The primary outcome measured was the bacterial conversion, while secondary outcomes included medication adherence and the quality of TB patients’ lives. Using an individually randomized sample, 100 patients (50 patients per group) were selected. The instruments used included the medication adherence rating scale-5, knowledge questionnaire, and St. George's Respiratory Questionnaire. Data were analyzed with Mann-Whitney test. A significant difference was observed in the knowledge scores between the control and experimental groups, indicated by a p-value of 0.007 (p < 0.05). The experimental group showed a higher median score (76.92) compared to the control group (61.54). Significant differences were also observed in the medication (p = 0.008, p < 0.05). In the experimental group, 50 patients demonstrated higher medication adherence (median score 25.00). Regarding patients’ quality of life, a significant difference was observed between the two groups. The control experimental group had better quality of life. Overall, the study concluded that telecare-based interprofessional collaboration had a positive impact on improving knowledge, medication adherence, quality of life in TB patients and bacterial conversion.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Ministry of Health of the Republic of Indonesia. National guidelines for tuberculosis control. Jakarta: Ministry of Health; 2014.
2. Izudi J, Okello G, Bajunirwe F. Low treatment success rate among previously treated persons with drug-susceptible pulmonary tuberculosis in Kampala, Uganda. J Clin Tuberc other Mycobact Dis. 2023;32:100375. doi:10.1016/j.jctube.2023.100375.
3. Schoenbaechler V, Guilavogui Y, Onivogui S, Hébélamou J, Mugglin C, Furrer H, Hensen Corina, Bavogui EB, Kolie C, Zoumanigui P, Béavogui I, Leuenberger D, Staehelin C. Rate of treatment success and associated factors in the program for drug-susceptible tuberculosis in the Forest Region, Republic of Guinea, 2010-2017: A real-world retrospective observational cohort study. Int J Infect Dis. 2021;110:6–14.
4. Pameswari P, Halim A, Yustika L. Level of compliance of tuberculosis patients at Mayjen H.A. Thalib Kerinci Hospital. J Clin Pharm Sci. 2016;2(2):116–121.
5. Rahem A, Priyandani Y, Djunaedi M. The correlation between belief and adherence to therapeutic regimens in pharmaceutical care for tuberculosis patients in primary healthcare centres in Surabaya, Indonesia. Trop J Nat Prod Res. 2020;4(8):355-359. doi:10.26538/tjnpr/v4i8.6.
6. Azalla CR, Maidar, Ismail N. Quality of life and treatment adherence among pulmonary tuberculosis patients in Pidie Jaya District. J Aceh Med. 2020;4(2):122–136.
7. Atif M, Syed SS, Shafie A, Asif M, Sarfraz M, Low H, Babar Z. Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study. Health Qual Life Outcomes. 2014;12(1):19.
8. Endria V, Yona S. Depression and tuberculosis-related stigma associated with quality of life in patients with pulmonary tuberculosis. Natl Health Res J. 2019;3(1):21–8.
9. Arjuna A, Sukihananto S. Mobile health as an effort to improve treatment success in tuberculosis patients: a literature review. Citra Delima J Ilm STIKES Citra Delima. 2019;2(2):89–94.
10. Octavia DR, Hermansyah A, Nita Y, Priyandani Y, Pristianty L, Ming LC, Alsaleh NA, Alsharif AA, Meilianti S. The adherence–quality of life paradox in tuberculosis care after COVID-19: a cross-sectional study in Indonesia. Discov Public Health. 2025;22(1):704. doi:10.1186/s12982-025-01111-6.
11. Gashu KD, Gelaye KA, Mekonnen ZA, Lester R, Tilahun B. Does phone messaging improves tuberculosis treatment success? A systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1-13. doi:10.1186/s12879-020-4765-x
12. Iskandar D, Pradipta IS, Anggriani A, Postma MJ, van Boven JFM. Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacists. BMJ Open Respir Res. 2023;10(1):1-11. doi:10.1136/bmjresp-2023-001887.
13. Pradipta IS, Yanuar EO, Nurhijriah CY, Maharani NP, Subra L, Destiani DP, Diantini A. Practical models of pharmaceutical care for improving tuberculosis patient detection and treatment outcomes: a systematic scoping review. Trop Med Infect Dis. 2023;8(5).
14. Bosch B, Mansell H. Interprofessional collaboration in health care: Lessons to be learned from competitive sports. Can Pharm J. 2015;148(4):176-179. doi:10.1177/1715163515588106.
15. Bosch B, Mansell H. Interprofessional collaboration in health care: Lessons to be learned from competitive sports. Can Pharm J. 2015;148(4):176-179. doi:10.1177/1715163515588106
16. Wetherell JL, Petkus AJ, Thorp SR, Stein MB, Chavira DA, Campbell-Sills L, Craske MG, Sherbourne C, Bystritsky A, Sullivan G, Byrne PR. Age differences in treatment response to a collaborative care intervention for anxiety disorders. Br J Psychiatry. 2013;203(1):65–72.
17. Bachina P, Lippincott CK, Perry A, Munk E, Maltas G, Bohr R, Rock RB, Shah M. Programmatic adoption and implementation of video-observed therapy in Minnesota: prospective observational cohort study. JMIR Form Res. 2022;6(8):e38247.
18. Park S, Sentissi I, Gil SJ, Park WS, Oh BK, Son AR, Kong YJ, Park S, Paek E, Park YJ, Lee SH. Medication event monitoring system for infectious tuberculosis treatment in Morocco: A retrospective cohort study. Int J Environ Res Public Health. 2019;16(3).
19. Ulandari S, Rahem A, Priyandani Y. An evaluation of the validity and reliability of the tuberculosis patient knowledge questionnaire. Pharm Educ. 2024;24(3):173-177. doi:10.46542/pe.2024.243.173177
20. Adnan A, Perwitasari DA, Mulyani UA. Reliability and validity of the St George’s Respiratory Questionnaire (SGRQ) Indonesian version. Int J Public Health Sci. 2014;3(3):179–186. doi:10.11591/ijphs.v3i3.4691
21. Ridho A, Alfian SD, Van BJFM, Levita J, Yalcin EA, Le L, Alffenaar JW, Hak E, Abdulah R, Pradipta IS. Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: Systematic review of randomized controlled trials. J Med Internet Res. 2022;24(2):e33062.
22. Lam CK, Pilote KMG, Haque A, Burzynski J, Chuck C, Macaraig M. Using video technology to increase treatment completion for patients with latent tuberculosis infection on 3-month isoniazid and rifapentine: An implementation study. J Med Internet Res. 2018;20(11). doi:10.2196/jmir.9825
23. Holzman SB, Zenilman A, Shah M. Advancing patient-centered care in tuberculosis management: a mixed-methods appraisal of video directly observed therapy. Open Forum Infect Dis. 2018 Apr;5(4):ofy046.
24. Guo P, Qiao W, Sun Y, Liu F, Wang C. Telemedicine technologies and tuberculosis management: A randomized controlled trial. Telemed e-Health. 2020;26(9):1150-1156. doi:10.1089/tmj.2019.0190.
25. Abubakar A, Asih BO, Cabu R. Patient adherence to tuberculosis treatment at the Maba City Health Center, East Halmahera. Leleani J Nurs Public Health. 2022;2(1):27–34.
26. Tukayo IJH, Hardyanti S, Madeso MS. Factors influencing adherence to anti-tuberculosis medication among pulmonary tuberculosis patients at Waena Primary Health Center. J Trop Papua Nurs. 2020;3(1):145–150.
27. Garfein RS, Doshi RP. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J Clin Tuberc Other Mycobact Dis. 2019;17:100098. doi:10.1016/j.jctube.2019.100098.
28. Yunitasari R, Akbar IB, Nurmeliani R. Correlation between the performance of directly observed treatment supervisors and medication adherence among pulmonary tuberculosis patients. Bandung Conf Ser Med Sci. 2023;3(1):19–24. doi:10.29313/bcsms.v3i1.5478.
29. Octavia DR, Hermansyah A, Nita Y. The readiness and acceptance of patients with tuberculosis to use telecare. Pharm Educ. 2024;24(3):251-255. doi:10.46542/pe.2024.243.251255.
30. Octavia DR, Hermansyah A, Nita Y, Zairina E. Enhancing tuberculosis patient safety: The impact of interprofessional collaboration based telecare on drug-related problems in a randomized control trial. Indian J Tuberc. 2025;(April). doi:10.1016/j.ijtb.2025.04.010.
31. Pujihastuti N, Priyo P, Priyanto S. Whatsapp reminder and educational video to improve pulmonary tuberculosis patient control compliance during the pandemic. Media Keperawatan Indones. 2022;5(4):280-287.
32. Mulyani ES. Effect of video-based education on knowledge, attitude, and treatment adherence among pulmonary tuberculosis patients at the Klaten Regional Public Health Center. Gastron Ecuatoriana Tur Local. 2019;1(69):5–24.
33. Rachma W, Makhfudli, Wahyuni S. Effect of health education on knowledge and attitudes of pulmonary tuberculosis patients. Muhammadiyah Nurs J. 2021;6(3):137–149.
34. Sriwijaya RA, Kumala S, Keban SA. The effect of pharmacist education on therapeutic outcomes of pulmonary TB patients in the intensive phase at Persahabatan hospital, March–July 2015. Journal of Science Research. 2018;20(September):86–91.
35. Suarnianti, Selan C, Sumi S. Evaluation of peer group support and family support on treatment adherence among pulmonary tuberculosis patients: literature review. Health Sci Rev J. 2021;11(3):9–11.
36. Nataprawira H, Tirtosudiro A, Primaturia C, Hasbrima S. Effect of poster and leaflet media intervention on knowledge, attitudes, and behavior of Islamic boarding school students in Karawang District regarding tuberculosis. Indones Public Health J. 2018;5(2):123–9.
37. Mutasar A, Irawan A, Kabuhung IE. Effect of android-based electronic media on improving tuberculosis patient knowledge: a literature review. Proc Sari Mulia Univ Nurs Natl Semin. 2020;2(4):25–37.
38. Aliva M, Rahayu H, Margowati S. Effect of health promotion through leaflet and WhatsApp media on adherence to iron tablet consumption among pregnant women. Indones J Midwifery. 2021;5(2):45–49.
39. Kamel Boulos MN, Giustini DM, Wheeler S. Instagram and WhatsApp in health and healthcare: An overview. Futur Internet. 2016;8(3):1-14. doi:10.3390/fi8030037.


